What we did here is look at tissue in 3D and then map the genetic alterations onto that 3D model,” explained Laura Wood, M.D., Ph.D., Associate Professor of Pathology and Oncology at the Johns Hopkins ...

CODA, the first ever 3D genome profiling technique, was able to make a 3D print of pre-cancerous cells found in a human ...

A new study provides more evidence that GLP-1 RAs don’t raise the risk for pancreatic cancer and may in fact offer some protection.

Expands DNAbilize® Technology Beyond Oncology into Obesity Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) -- , (NASDAQ:BPTH), a biotechnology company ...

In the oral presentation, the investigators reported ongoing improved survival compared to historical controls, with 3 out of ...

Expands DNAbilize® Technology Beyond Oncology into Obesity Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotech ...

Mass spectrometry and machine learning show promise for early cancer detection and prognosis by analyzing metabolic ...

AIP mimics pancreatic cancer and it is critically important ... For example, the Japanese Pancreas Society (2002 and 2006) and Histology, Imaging, Serology, Other Organ Involvement and Response ...

The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, ...

Agem Capital Group, a capital market advisory boutique for private investment firms and growth companies, announced today its ...

AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC ...